Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

A New Oral BTK Protein Degrader: A novel drug designed to overcome resistance to BTK Inhibitors

Featuring Dr. Brian Koffman and Dr. Adrian Wiestner

For more information on the Clinical Trial, please visit:

Find CLL Society on Social Media

Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.